## CLX: The Clorox Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -5.7% below STRENGTH zone (4.0-10.0%); PEG 3.23 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($93.45)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Clorox stock hits 52-week low at 98.04 USD**
- Source: Investing.com | 20251222T143731 | Somewhat-Bearish | Relevance: 100%
- Clorox Co.'s stock has fallen to a new 52-week low of $98.04, reflecting a significant 39.72% decrease over the past year despite the company surpassing market expectations in its Q1 fiscal year 2026 earnings report. Jefferies adjusted its price target from $155 to $152 but maintained a Buy rating, acknowledging the better-than-expected performance. Stakeholders are now closely monitoring the company's response to this downward trend in its stock price.

**2. Who Owns The Clorox Company? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251220T210754 | Neutral | Relevance: 100%
- This article analyzes the major shareholders and recent insider trading activities of The Clorox Company (NYSE: CLX). It highlights that institutional investors, particularly passive ones like Vanguard and State Street, dominate ownership, maintaining stability despite recent share price declines. While some hedge funds are increasing their stakes, insider transactions show cautious selling, with limited buying, implying a valuation-aware stance from investors amid margin pressures and slower growth expectations.

**3. Texas Permanent School Fund Corp Increases Position in The Clorox Company $CLX**
- Source: MarketBeat | 20251220T100803 | Somewhat-Bearish | Relevance: 100%
- Texas Permanent School Fund Corp significantly increased its stake in The Clorox Company by 92.9% in the 2nd quarter, purchasing an additional 12,072 shares to hold a total of 25,063 shares valued at approximately $3.01 million. Analysts have maintained a "Reduce" consensus rating for CLX with an average price target of $125. The company beat quarterly EPS estimates but saw an 18.9% revenue decline year-over-year, while also announcing a $1.24 quarterly dividend.

**4. Assenagon Asset Management S.A. Acquires 131,233 Shares of The Clorox Company $CLX**
- Source: MarketBeat | 20251220T080741 | Neutral | Relevance: 100%
- Assenagon Asset Management S.A. significantly increased its stake in The Clorox Company, purchasing an additional 131,233 shares and now holding 186,278 shares valued at approximately $22.97 million. This move comes as Clorox reported quarterly EPS beating forecasts despite a revenue decline, and declared a quarterly dividend of $1.24 per share, offering an annualized yield of 5.0%. Institutional investors own a substantial portion of Clorox stock, with other hedge funds also adjusting their positions.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $109 | $120 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($10.20M) |
| Sells | 11 ($0.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 3.2x requires aggressive growth execution.
3. Long-term trend broken: trading 21.3% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.23 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($10.2M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 0.57 |
| 52W Range | $97.39 - $164.41 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.23 |
| Forward P/E | 14.5 |
| Current P/E | 16.4 |
| YoY Growth | 12.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -3.5% to -5.7% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.7pp (needs >4.0% for momentum thesis). AM_20 at -5.1% indicates price below own 20MA trend. Underperforming sector by 4.0pp, stock-specific weakness. Below SMA200 (0.79x), long-term trend not supportive. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.65% (CS: 6) | Weak |
| RSI_14 | 33.7 | Neutral |
| MACD Histogram | -0.23 | Bearish |
| vs SMA20 | 0.949x | Below |
| vs SMA50 | 0.910x | Below |
| vs SMA200 | 0.787x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $98.05
- **Stop Loss:** $93.45 (4.7% risk)
- **Target:** $102.65 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 130
- **Position Value:** $12,746.50
- **Portfolio %:** 12.75%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*